Stocks Technology BHIC
OTC · TechnologyBioScience Health Innovations, Inc. (BHIC)
BioScience Health Innovations, Inc. brought in $4.5M of revenue over the twelve months to June 30, 2026, up 7.8% from a year earlier. It posted a net loss of $658.1K. At June 30, 2026 it held $712.4K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 7, 2026.
Watch BHIC in 60 secondsWhat BioScience Health Innovations, Inc. does
BioScience Health Innovations, Inc. is registered with the SEC under industry code SIC 7374 (Services-Computer Processing & Data Preparation). Its shares trade on OTC under the ticker BHIC.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $5.7M | $642.1K | $0.06 | n/a |
| 2024 | $1.8M | $87K | $0.01 | n/a |
| 2023 | $597.6K | -$251.5K | -$0.01 | n/a |
| 2023 | $69.3K | -$170.5K | n/a | n/a |
| 2022 | $0 | -$83.2K | n/a | n/a |
| 2021 | $0 | -$25.6K | $0.00 | n/a |
Full financial statements: income, balance sheet and cash flow
Where BHIC ranks in Technology
Latest SEC filings
What BioScience Health Innovations, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 7, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 41% to $1M versus the same quarter last year; diluted EPS -$0.02 versus $0.04.
- July 9, 2026Form QUALIF filing QUALIF
- July 6, 2026Form 1-A POS filing 1-A POS
- May 11, 2026Quarterly report 10-Q · period to March 31, 2026Revenue fell 39% to $750.9K versus the same quarter last year; diluted EPS -$0.02 versus $0.01.
- April 2, 2026
- March 30, 2026Annual report 10-K · period to December 31, 2025Revenue rose 208% to $5.7M versus the prior year; diluted EPS $0.06 versus $0.01.
- December 4, 2025Form QUALIF filing QUALIF
- November 25, 2025Form 1-A filing 1-A
- October 27, 2025Quarterly report 10-Q · period to September 30, 2025Revenue rose 97% to $1.1M versus the same quarter last year; diluted EPS $0.00 versus $0.01.
- October 16, 2025
Questions about BHIC
What does BioScience Health Innovations, Inc. do?
BioScience Health Innovations, Inc. is registered with the SEC under industry code SIC 7374 (Services-Computer Processing & Data Preparation). Its shares trade on OTC under the ticker BHIC.
Is BioScience Health Innovations, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $658.1K on revenue of $4.5M.
How much revenue does BioScience Health Innovations, Inc. make?
Over the twelve months to June 30, 2026 BioScience Health Innovations, Inc. reported revenue of $4.5M. That is 7.8% more than a year earlier.
When did BioScience Health Innovations, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 7, 2026. It covers the period to June 30, 2026.
Similar companies
Compare BHIC with
Follow BHIC
Get an email when BioScience Health Innovations, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow BHIC: get an email when it filesWhere the numbers come from
Financial figures are the values BioScience Health Innovations, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.